Cathy Garabedian

Cathy Garabedian is an experienced executive in the pharmaceutical and biotechnology industries, currently serving as Executive Director of New Product Planning at Keros Therapeutics. Previously held the position of Senior Director of New Product Planning at both X4 Pharmaceuticals and Sage Therapeutics, where significant contributions included directing global marketing for Sage-217. Additionally, Cathy has worked at Alkermes as Director of Marketing and Associate Director of New Product Planning, as well as at Sunovion/Sepracor Pharmaceuticals in business development management roles. This extensive background underscores a strong focus on new product planning and marketing within the sector.